戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ac magnetic resonance imaging, or nonimaging exercise tolerance test.
2 d point but not after adjusting for positive exercise tolerance testing.
3  disease events (relative risk with abnormal exercise tolerance testing, 2.0 to 5.0).
4 cumented coronary artery disease, a positive exercise tolerance test, and stable chronic angina pecto
5 nsional echocardiography, Holter monitoring, exercise tolerance testing, and ajmaline provocation.
6 ography, cardiac magnetic resonance imaging, exercise tolerance testing, and biomarker assessment.
7 , CA, and Washington DC, USA, who had had an exercise tolerance test between 1986, and 2011.
8 principally in middle-aged men, suggest that exercise tolerance testing can provide independent progn
9 dulthood caused male mice to underperform at exercise tolerance tests compared to their control and f
10                                    Treadmill exercise tolerance testing demonstrated impaired exercis
11                                    Treadmill exercise tolerance testing demonstrated impaired perform
12                           Although screening exercise tolerance testing detects severe coronary arter
13             Noninvasive stress imaging or an exercise tolerance test (ETT) are the most common method
14 a and enhances functional capacity during an exercise tolerance test (ETT) in patients with coronary
15 on or myocardial infarction (MI), with a pre-exercise tolerance test (ETT) likelihood of CAD > or =0.
16 postinfarction angina or a strongly positive exercise tolerance test (ETT) typically had cost-effecti
17 , exercise, and nuclear models by use of pre-exercise tolerance test (ETT), post-ETT, and nuclear inf
18  depression > or =1 mm from baseline) during exercise tolerance testing (ETT) was examined in patient
19                                              Exercise tolerance testing has been proposed as a means
20 le cohort studies demonstrate that screening exercise tolerance testing identifies a small proportion
21 Efficacy was evaluated at 90 and 180 days by exercise tolerance test, myocardial nuclear perfusion im
22 netic resonance imaging (n=108; r=0.31), and exercise tolerance test (n=1134; r=0.18).
23 dical treatment and, if stable, predischarge exercise tolerance testing (n = 1106).
24 chocardiography, magnetic resonance imaging, exercise tolerance testing, n=5105, 99%).
25                         Deterioration in all exercise tolerance test parameters occurred in patients
26  to limiting angina during bicycle exercise (exercise tolerance tests), performed at trough of drug a
27 s were similar in the 2 approaches, with the exercise tolerance test result exerting the greatest lev
28                                    Treadmill exercise tolerance testing (TETT) demonstrated improved
29 ta-blocker therapy underwent cardiopulmonary exercise tolerance testing under 2 conditions in random